Refametinib
STEMCELL Technologies Inc.MEK/ERK pathway inhibitor; Inhibits MEK1 and MEK2
MEK/ERK pathway inhibitor; Inhibits MEK1 and MEK2
Activin/Nodal/TGFß pathway inhibitor; Inhibits ALK5
Activin/BMP/TGF-ß pathway inhibitor; Inhibits ALK5
Adenosine receptor, non-muscle myosin II (NM II), MEK1, and aurora kinase inhibitor
Epigenetic modifier; Inhibits DNA methyltransferase (DNMT)
RHO/ROCK pathway inhibitor; Inhibits ROCK2
cAMP pathway activator; Inhibits type 4 cyclic nucleotide phosphodiesterases (PDE4)
Epigenetic modifier; Inhibits DNA methyltransferase (DNMT)
JAK/STAT pathway inhibitor; Inhibits JAK1 and JAK2
Hedgehog pathway activator; Activates Smoothened (SMO)
WNT pathway activator; Inhibits GSK3a and GSK3ß
Activin/BMP/TGF-ß pathway inhibitor; Inhibits ALK4, ALK5, and ALK7
Epigenetic modifier; Inhibits DNA methyltransferases (DNMTs)
Epigenetic modifier; Inhibitor of Sir2p, SIRT1, and SIRT2
Activin/NODAL/TGF-ß pathway inhibitor; Inhibits SMAD3
Immunomagnetic positive selection cell isolation kit